Overview
- 82 inspections across 73 sites are on record.
- 375 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-30.
At a glance
Inspections
82
Sites
73
Observations
375
Career since
Jul 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Novo Nordisk Pharmaceutical Industries, LP | 30 Jun 2026 | Human Drugs | |
| Endo USA, Inc. | 5 Jun 2026 | Human Drugs | On file |
| PPL Healthcare LLC | 8 May 2026 | Human Drugs | View 483 → |
| Granules Pharmaceuticals Inc. | 3 Apr 2026 | Human Drugs | View 483 → |
| Aphena Pharma Solutions - Maryland, LLC | 20 Feb 2026 | Human Drugs | View 483 → |
Sites inspected
Novo Nordisk Pharmaceutical Industries, LPPetersburg, United States1 insp.
Endo USA, Inc.Horsham, United States1 insp.
PPL Healthcare LLCSellersville, United States1 insp.
Granules Pharmaceuticals Inc.Chantilly, United States1 insp.
Aphena Pharma Solutions - Maryland, LLCEaston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Kenneth H Williams6 shared
Craig D Zagata6 shared
Kara J Wright4 shared
Daniel J Min4 shared
Christina K Theodorou4 shared
Daniel T Lee3 shared
Lisa Shin3 shared
Freddy Ortiz Colon3 shared
Matthew R Noonan3 shared
Ofuje D Daniyan2 shared
Full investigator report
Get the verbatim findings behind David A Oluwo's 375 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site